Michael Robin Witt
Amministratore Delegato presso GABATHER AB
Posizioni attive di Michael Robin Witt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GABATHER AB | Direttore/Membro del Consiglio | 01/09/2014 | - |
| Amministratore Delegato | 01/10/2018 | - | |
| Contatto Relazioni con gli Investitori | - | - | |
| Lead Discovery Malaysia Sdn. Bhd. | Amministratore Delegato | 01/01/2012 | - |
| Direttore Tecnico/Scientifico/R&S | 01/01/2012 | - |
Storia della carriera di Michael Robin Witt
Precedenti posizioni note di Michael Robin Witt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Direttore Tecnico/Scientifico/R&S | 01/09/2010 | 01/04/2012 |
| Fondatore | 01/01/2007 | 01/04/2012 | |
| KARO PHARMA AB (PUBL) | Direttore Tecnico/Scientifico/R&S | 01/01/2002 | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - | - |
| NTG NORDIC TRANSPORT GROUP A/S | Corporate Officer/Principal | - | - |
Formazione di Michael Robin Witt
| Vrije Universiteit Brussel | Doctorate Degree |
| Danmarks Farmaceutiske Universitet | Doctorate Degree |
Statistiche
Distribuzione geografica
| Svezia | 5 |
| Danimarca | 3 |
| Belgio | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
| Transportation | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| KARO PHARMA AB (PUBL) | Health Technology |
| GABATHER AB | Health Technology |
| Aziende private | 3 |
|---|---|
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
| Lead Discovery Malaysia Sdn. Bhd. |
- Borsa valori
- Insiders
- Michael Robin Witt
- Esperienza
